Proyectos de Investigación
Project LABAE222982TEIJ
XPRIME, Exploring and exploiting crosspriming in cancer immunotherapy
edit_calendar
Duration: from 01 December 2022 to 30 November 2025
(36 months)
Current
euro
299,639.00 EUR
Of National scope.